206 related articles for article (PubMed ID: 21750124)
1. Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors.
Airoldi I; Ribatti D
J Leukoc Biol; 2011 Nov; 90(5):875-82. PubMed ID: 21750124
[TBL] [Abstract][Full Text] [Related]
2. Cancer CXC chemokine networks and tumour angiogenesis.
Strieter RM; Burdick MD; Mestas J; Gomperts B; Keane MP; Belperio JA
Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
4. The indirect antiangiogenic effect of IL-37 in the tumor microenvironment.
Mei Y; Zhu Y; Teo HY; Liu Y; Song Y; Lim HY; Binte Hanafi Z; Angeli V; Liu H
J Leukoc Biol; 2020 May; 107(5):783-796. PubMed ID: 32125036
[TBL] [Abstract][Full Text] [Related]
5. CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.
Santoni M; Bracarda S; Nabissi M; Massari F; Conti A; Bria E; Tortora G; Santoni G; Cascinu S
Biomed Res Int; 2014; 2014():768758. PubMed ID: 24971349
[TBL] [Abstract][Full Text] [Related]
6. Understanding the immunoangiostatic CXC chemokine network.
Balestrieri ML; Balestrieri A; Mancini FP; Napoli C
Cardiovasc Res; 2008 May; 78(2):250-6. PubMed ID: 18252760
[TBL] [Abstract][Full Text] [Related]
7. Angiostatic activity of the antitumor cytokine interleukin-21.
Castermans K; Tabruyn SP; Zeng R; van Beijnum JR; Eppolito C; Leonard WJ; Shrikant PA; Griffioen AW
Blood; 2008 Dec; 112(13):4940-7. PubMed ID: 18515660
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-mediated effects on angiogenesis in solid tumors.
Martens B; Drebert Z
J Steroid Biochem Mol Biol; 2019 Apr; 188():147-155. PubMed ID: 30654109
[TBL] [Abstract][Full Text] [Related]
9. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
[TBL] [Abstract][Full Text] [Related]
10. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
Li S; Zhang X; Xia X
J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
[TBL] [Abstract][Full Text] [Related]
11. CXCR3, a double-edged sword in tumor progression and angiogenesis.
Billottet C; Quemener C; Bikfalvi A
Biochim Biophys Acta; 2013 Dec; 1836(2):287-95. PubMed ID: 23994549
[TBL] [Abstract][Full Text] [Related]
12. sFLT01: a novel fusion protein with antiangiogenic activity.
Bagley RG; Kurtzberg L; Weber W; Nguyen TH; Roth S; Krumbholz R; Yao M; Richards B; Zhang M; Pechan P; Schmid S; Scaria A; Kaplan J; Teicher BA
Mol Cancer Ther; 2011 Mar; 10(3):404-15. PubMed ID: 21252283
[TBL] [Abstract][Full Text] [Related]
13. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
Maes H; Olmeda D; Soengas MS; Agostinis P
FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy.
Rivera LB; Meyronet D; Hervieu V; Frederick MJ; Bergsland E; Bergers G
Cell Rep; 2015 Apr; 11(4):577-91. PubMed ID: 25892230
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effect of radiation on angiogenic and angiostatic CXC chemokine expression in human endothelial cells.
Chang CC; Lerman OZ; Thanik VD; Scharf CL; Greives MR; Schneider RJ; Formenti SC; Saadeh PB; Warren SM; Levine JP
Cytokine; 2009 Dec; 48(3):295-302. PubMed ID: 19782578
[TBL] [Abstract][Full Text] [Related]
16. Breast tumor cell soluble factors induce monocytes to produce angiogenic but not angiostatic CXC chemokines.
Toulza F; Eliaou JF; Pinet V
Int J Cancer; 2005 Jun; 115(3):429-36. PubMed ID: 15688373
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.
Quintieri L; Selmy M; Indraccolo S
Biochem Pharmacol; 2014 May; 89(2):162-70. PubMed ID: 24607274
[TBL] [Abstract][Full Text] [Related]
18. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
[TBL] [Abstract][Full Text] [Related]
19. Chemokines as mediators of neovascularization.
Keeley EC; Mehrad B; Strieter RM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1928-36. PubMed ID: 18757292
[TBL] [Abstract][Full Text] [Related]
20. Chemokines.
Hippe A; Homey B; Mueller-Homey A
Recent Results Cancer Res; 2010; 180():35-50. PubMed ID: 20033377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
